Sun Pharmaceuticals Industries Ltd

NSE :SUNPHARMA   BSE :524715  Sector : Pharmaceuticals
Buy, Sell or Hold SUNPHARMA? Ask The Analyst

BSE


prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE


prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

15 Jun
673.20
(-0.58%)
14 Jun
677.10
(-0.62%)
11 Jun
681.30
(0.78%)
10 Jun
676.05
(0.48%)
09 Jun
672.85
(-0.87%)
08 Jun
678.75
(0.50%)
07 Jun
675.35
(0.21%)
04 Jun
673.95
(-0.23%)
03 Jun
675.50
(-0.29%)
02 Jun
677.45
(0.95%)
01 Jun
671.05
(0.41%)
31 May
668.30
(-0.22%)
28 May
669.75
(-4.25%)
27 May
699.50
(-0.61%)
26 May
703.80
(1.11%)
25 May
696.10
(0.75%)
24 May
690.95
(0.08%)
21 May
690.40
(0.52%)
20 May
686.85
(-2.35%)
19 May
703.40
(1.82%)
18 May
690.80
(0.53%)


Technical Analysis

Short Term Investors

Very Bearish

Medium Term Investors

Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bearish

676.12


10 DMA
Bearish

676.19


20 DMA
Bearish

682.08


50 DMA
Bullish

663.64


100 DMA
Bullish

633.88


200 DMA
Bullish

582.06



Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Jun 15, 2021 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 688.8 685.1 675.85 - -
R2 685.1 681.41 674.97 684.54 -
R1 679.15 679.14 674.08 678.03 682.13
P 675.45 675.45 675.45 674.89 676.94
S1 669.5 671.76 672.32 668.38 672.48
S2 665.8 669.49 671.43 665.24 -
S3 659.85 665.8 670.55 - -

Key Metrics

EPS

9.29

P/E

72.47

P/B

6.45

Dividend Yield

1.11%

Market Cap

1,61,523 Cr.

Face Value

1

Book Value

104.36

ROE

9.66%

EBITDA Growth

1,485.63 Cr.

Debt/Equity

0.22

Shareholding Pattern

  54.48% Total Promoter Holding
11.93% Mutual Fund Holdings
11.67% FIIs
12.23% Non Institution
9.02% Insurance Companies
0% Custodians
0.67% Other Parties

Shareholding History


Quarterly Result (Figures in Rs. Crores)


Sun Pharmaceuticals Industries Ltd Quaterly Results


Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021
INCOME 8287.17 7739.04 9097.19 9151.73 8633.98
PROFIT 622.98 1731.82 1524.51 1852.48 1525.95
EPS 1.67 -6.9 7.56 7.72 3.7

Sun Pharmaceuticals Industries Ltd Quaterly Results


Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021
INCOME 4054.73 2984.23 3365.69 3409 3194.51
PROFIT 1155.85 531.95 724.81 555.55 406.41
EPS 4.82 2.22 3.02 2.32 1.36

Profit & Loss (Figures in Rs. Crores)


Sun Pharmaceuticals Industries Ltd Profit & Loss


Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
INCOME 6288.45 8939.87 11916.43 16709.13 27825.18 29539.05 32473.22 27097.52 30524.51 33188.24
PROFIT 1777.14 2453.74 3367.44 4978.84 4581.78 5027.37 6932.28 2794.9 3661.85 3942.56
EPS 8.93 14.35 16.33 18.47 25.79 23.51 32.66 10.7 13.38 17.45

Sun Pharmaceuticals Industries Ltd Profit & Loss


Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
INCOME 3299.71 4440.57 2679.28 3021.08 7921.92 8178.89 8366.9 9951.27 11825.95 13904.25
PROFIT 1346.81 1824.77 493.08 -59.51 -1560.14 -1349.86 -266.99 1114.26 1865.28 3007.17
EPS 6.4 7.85 2.07 0 0 0 0 1.27 3.4 13.38

Balance Sheet (Figures in Rs. Crores)

Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
SOURCES OF FUNDS :
Share Capital 239.93239.93239.93239.93240.66207.12207.12103.56103.56103.56
Reserves Total 45,024.5241,169.1338,074.1836,399.7432,741.1525,382.5918,317.8314,886.1712,132.229,379.76
Equity Application Money00000.6748.380000
Total Shareholders Funds45,264.4541,409.0638,314.1136,639.6732,982.4825,638.0918,524.9514,989.7312,235.789,483.32
Minority Interest3,860.243,313.543,884.163,790.864,085.252,851.191,921.181,635.081,161.45847.15
Secured Loans 257.49109.47114.35780.45284.23339.9974.94105.11131.91109.69
Unsecured Loans 8,057.3910,404.8910,270.929,051.328,212.538,656.122,485.92154.6188.82315.89
Total Debt8,314.8810,514.3610,385.279,831.778,496.768,996.112,560.86259.71320.73425.58
Other Liabilities1,334.281,004.7462.711,341.822,105.512,718.682,610.76796147.6619.68
Total Liabilities58,773.8556,241.6653,046.2551,604.1247,67040,204.0725,617.7517,680.5213,865.6210,775.73
APPLICATION OF FUNDS :
Gross Block 35,115.9731,687.0426,948.8124,466.4222,180.4120,406.8310,485.128,709.226,448.665,319.27
Less: Accumulated Depreciation12,269.069,850.58,096.166,791.256,308.167,724.363,667.843,061.752,497.312,025.92
Net Block22,846.9121,836.5418,852.6517,675.1715,872.2512,682.476,817.285,647.473,951.353,293.35
Capital Work in Progress1,220.341,411.152,465.162,801.382,175.452,038.61841.54562.61344.65235.46
Investments 10,143.117,902.537,142.871,191.881,829.882,716.32,786.022,411.572,212.872,229.76
Inventories 7,874.997,885.986,880.696,832.816,422.545,667.993,123.012,577.762,086.981,489.48
Sundry Debtors 9,421.248,884.27,815.287,202.616,775.665,106.132,200.422,412.232,078.741,104.87
Cash and Bank Balance6,487.557,275.69,929.3815,140.8413,181.6510,998.047,590.154,058.713,367.192,204.63
Loans and Advances 2,973.023,072.692,919.933,546.512,847.645,026.163,774.421,149.111,136.55910.32
Total Current Assets26,756.827,118.4727,545.2832,722.7729,227.4926,798.3216,68810,197.818,669.465,709.3
Current Liabilities 5,248.265,288.66,008.655,328.34,536.854,166.361,516.821,215.141,300.64947.28
Provisions 4,172.213,059.275,242.494,163.033,220.654,352.761,960.581,481.661,152.54515.3
Total Current Liabilities & Provisions9,420.478,347.8711,251.149,491.337,757.58,519.123,477.42,696.82,453.181,462.58
Net Current Assets17,336.3318,770.616,294.1423,231.4421,469.9918,279.213,210.67,501.016,216.284,246.72
Deferred Tax Assets4,141.53,441.013,095.52,994.373,560.312,245.841,199.97927.66711.86500.06
Deferred Tax Liability1,024.35990.42907.13816.34514.09494.2288.95215.42183.55134.83
Net Deferred Tax3,117.152,450.592,188.372,178.033,046.221,751.64911.02712.24528.31365.23
Other Assets4,110.013,870.256,103.064,526.223,276.212,735.851,051.29845.62612.16405.21
Total Assets58,773.8556,241.6653,046.2551,604.1247,67040,204.0725,617.7517,680.5213,865.6210,775.73
Contingent Liabilities5,075.525,290.47,430.517,345.514,162.263,538.681,646.131,428.34686.94648.4
Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
SOURCES OF FUNDS :
Share Capital 239.93239.93239.93239.93240.66207.12207.12103.56103.56103.56
Reserves Total 24,156.2922,603.6822,082.6820,772.5421,649.3722,530.777,200.767,685.327,774.566,576.97
Equity Application Money00000.6748.380000
Total Shareholders Funds24,396.2222,843.6122,322.6121,012.4721,890.722,786.277,407.887,788.887,878.126,680.53
Secured Loans 6.189.7310.8230.632,939.46281.638.8143.1340.350.53
Unsecured Loans 6,399.76,426.916,873.196,015.982,889.386,529.052,400.2000
Total Debt6,405.886,436.646,884.016,046.615,828.846,810.682,409.0143.1340.350.53
Other Liabilities1,553.68176.19346.091,133.511,825.622,436.882,525.57132.5100.6510.87
Total Liabilities32,355.7829,456.4429,552.7128,192.5929,545.1632,033.8312,342.467,964.518,019.076,741.93
APPLICATION OF FUNDS :
Gross Block 8,244.717,461.346,572.664,988.084,103.75,995.071,973.531,725.141,483.031,268.76
Less : Accumulated Depreciation 3,015.972,482.921,928.09949.45529.082,809.8706.36589.35505.73474.37
Net Block 5,228.744,978.424,644.574,038.633,574.623,185.271,267.171,135.79977.3794.39
Capital Work in Progress596.61642.54987.841,100.5767.731,090.59480.46348.04248.87195.65
Investments 17,361.7217,904.1118,355.2619,333.322,371.6925,876.167,015.734,317.544,437.783,601.42
Inventories 2,633.672,792.622,135.642,308.282,132.152,189.25918.38868.76640.07618.26
Sundry Debtors 6,168.135,031.475,271.442,714.71,997.811,802.82980.15737.53713.48542.62
Cash and Bank Balance654.78340.77155.27170.28169.11416.46141.48431.121,327.711,250.91
Loans and Advances 2,089.472,756.961,968.11,154.92943.63947.822,799.43908.79444.62459.27
Total Current Assets11,546.0510,921.829,530.456,348.185,242.75,356.354,839.442,946.23,125.882,871.06
Current Liabilities 4,956.615,713.964,586.353,829.253,541.693,345.031,141.07507.66462.73311.74
Provisions 1,097.942,543.732,652.751,847.431,179.612,066.69688.03608.91515.49424.42
Total Current Liabilities & Provisions6,054.558,257.697,239.15,676.684,721.35,411.721,829.11,116.57978.22736.16
Net Current Assets5,491.52,664.132,291.35671.5521.4-55.373,010.341,829.632,147.662,134.9
Deferred Tax Assets1,704.221,427.47751.7751.7751.7389.3111.518.996.496.93
Deferred Tax Liability564.51675.7702.640389.31204.35174.4140.4135.44
Net Deferred Tax1,139.71751.7751.7749.06751.70-192.84-165.41-133.91-128.51
Other Assets2,537.52,515.542,521.992,299.61,558.021,937.18761.6498.92341.37144.08
Total Assets32,355.7829,456.4429,552.7128,192.5929,545.1632,033.8312,342.467,964.518,019.076,741.93
Contingent Liabilities3,090.93,639.135,708.855,636.82,584.822,016.32768.66838.67315.42107.49

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...5,009.59
Depreciation2,052.78
Interest (Net)-51.89
Dividend Received56.18
P/L on Sales of Assets5.22
Prov. and W/O (Net)101.74
P/L in Forex22.77
Others-702.03
Total Adjustments (PBT and Ext...1,992.54
Operating Profit before Workin...7,002.13
Trade and 0ther Receivables-374.05
Inventories256.77
Trade Payables-136.57
Total Adjustments (OP before W...898.55
Cash Generated from/(used in) ...7,900.68
Direct Taxes Paid-1,345.91
Total Adjustments(Cash Generat...-1,345.91
Cash Flow before Extraordinary...6,554.77
Net Cash from Operating Activi...6,554.77
Purchased of Fixed Assets-1,542
Sale of Fixed Assets92.03
Purchase of Investments-33,445.39
Sale of Investments31,893.63
Interest Received338.46
Net Cash used in Investing Act...-2,225.32
Proceed from 0ther Long Term B...10,551.57
Of the Long Tem Borrowings-13,893.46
Dividend Paid-1,399.33
Interest Paid-271.89
Net Cash used in Financing Act...-5,715.14
Net Profit before Tax and Extr...3,253
Depreciation561.56
Interest (Net)337.95
Dividend Received1,350.07
P/L on Sales of Invest-236.57
Prov. and W/O (Net)-193.38
P/L in Forex239.94
Others-623.77
Total Adjustments (PBT and Ext...-217.09
Operating Profit before Workin...3,035.91
Trade and 0ther Receivables-921.72
Inventories158.95
Trade Payables94.06
Total Adjustments (OP before W...-1,393
Cash Generated from/(used in) ...1,642.91
Direct Taxes Paid-337.06
Total Adjustments(Cash Generat...-337.06
Cash Flow before Extraordinary...1,305.85
Net Cash from Operating Activi...1,305.85
Purchased of Fixed Assets-571.8
Sale of Fixed Assets6.35
Purchase of Investments-14,866.25
Sale of Investments14,786.24
Interest Received28.35
Cancellation of Investment in ...869.91
Acquisition of Companies-150.87
Net Cash used in Investing Act...1,483.04
Proceed from 0ther Long Term B...10,554.06
Of the Long Tem Borrowings-11,267.18
Dividend Paid-1,379.19
Interest Paid-155.07
Net Cash used in Financing Act...-2,871.15

Company Details

Registered Office
AddressSun Pharma Advanced Res.Centre,
Tandalja
CityVadodara
StateGujarat
Pin Code390020
Tel. No.91-265-6615500
Fax. No.91-265-2354897
Emailsecretarial@sunpharma.com
Internethttp://www.sunpharma.com
Registrars
AddressSun Pharma Advanced Res.Centre
CityVadodara
StateGujarat
Pin Code390020
Tel. No.91-265-6615500
Fax. No.91-265-2354897
Emailsecretarial@sunpharma.com
Internethttp://www.sunpharma.com
Management
Name Designation
Dilip S Shanghvi Managing Director
Sudhir V Valia Non-Exec & Non-Independent Dir
Sailesh T Desai Whole-time Director
Sunil R Ajmera Company Secretary
Israel Makov Chairman (Non-Executive)
Rekha Sethi Non-Exec. & Independent Dir.
Kalyanasundaram Subramanian Whole-time Director
Vivek Chaand Sehgal Non-Exec. & Independent Dir.
Gautam Doshi Non-Exec. & Independent Dir.
Pawan Goenka Additional Director
Rama Bijapurkar Additional Director

Related Links


Top Stocks - Pharmaceuticals